Skip to content
Clemedi
  • Home
  • Team
  • Tuberculini
  • Awards
  • News
  • Jobs
  • Twitter
  • Facebook
  • LinkedIn

Day: October 31, 2022

Press Release
Oct 31, 2022

Press Release

Clemedi AG releases Tuberculini, its first molecular test for drug-resistant tuberculosis. Tuberculini is optimized to run on Thermo Fisher Scientific’s Ion GeneStudio S5™ System. Clemedi has developed a next-generation sequencing (NGS) based test called Tuberculini, that can recognise resistance to all major therapeutic agents used to treat tuberculosis. The assay – which received a CE-IVD…

read more
by Sebastian Dümckein Blog, Press releases0
  • Twitter
  • Facebook
  • LinkedIn
  • Terms and Conditions
  • Privacy Policy
© 2023 Clemedi. All rights reserved.
  • Twitter
  • Facebook
  • LinkedIn
Address:Wagistr. 12, 8952 Schlieren, Switzerland
Phone:+41 (0)43 229 38 21‬